Group B Streptococcus Vaccine Development Technology Roadmap
This report provides a strategic framework for group B Streptococcus (GBS) vaccine development. It identifies priority activities in four key categories—research; vaccine development; key capacities; and policy, commercialization, and delivery—that need to be undertaken in order to develop and license high-quality, safe, effective, and affordable GBS vaccines for maternal immunization during pregnancy to prevent GBS-related stillbirth and invasive disease in neonates and young infants globally.
Author: World Health Organization
» Download file (English)
551 KB PDF (Located at apps.who.int)
Resource types: Report
Diseases/vaccines: Group B Streptococcus (GBS)